Option Care Health, Inc. (NASDAQ:OPCH) Holdings Cut by Amalgamated Bank

Amalgamated Bank reduced its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 8.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 84,224 shares of the company’s stock after selling 8,233 shares during the period. Amalgamated Bank’s holdings in Option Care Health were worth $2,333,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of OPCH. Principal Securities Inc. purchased a new position in Option Care Health in the fourth quarter valued at about $27,000. Parallel Advisors LLC lifted its holdings in shares of Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after buying an additional 478 shares during the last quarter. TFO Wealth Partners LLC grew its stake in shares of Option Care Health by 24,625.0% in the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after buying an additional 985 shares in the last quarter. Park Place Capital Corp increased its holdings in Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares during the last quarter. Finally, Blue Trust Inc. raised its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Trading Down 1.1 %

NASDAQ:OPCH opened at $31.45 on Wednesday. The company’s 50 day moving average is $31.23 and its 200-day moving average is $30.44. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. Option Care Health, Inc. has a 12 month low of $26.11 and a 12 month high of $34.63. The firm has a market cap of $5.47 billion, a price-to-earnings ratio of 20.69, a P/E/G ratio of 2.46 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter last year, the firm posted $0.63 EPS. The business’s quarterly revenue was up 14.8% on a year-over-year basis. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on OPCH. JMP Securities began coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 target price for the company. Barrington Research upped their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.